ID   CIRAi004-A
AC   CVCL_UL56
SY   HPS3660
DR   hPSCreg; CIRAi004-A
DR   RCB; HPS3660
DR   SKIP; SKIP005532
DR   Wikidata; Q93453810
RX   PubMed=30605843;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30605843
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,19
ST   D5S818: 10,13
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 19,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=30605843; DOI=10.1016/j.scr.2018.101363;
RA   Niki T., Imamura K., Enami T., Kinoshita M., Inoue H.;
RT   "Establishment of human induced pluripotent stem cell line from a
RT   patient with Angelman syndrome carrying the deletion of maternal
RT   chromosome 15q11.2-q13.";
RL   Stem Cell Res. 34:101363-101363(2019).
//